PT Diastika Biotekindo Tbk
PT Diastika Biotekindo Tbk engages in the sale of disposable or consumable medical goods and diagnostic equipment. The company offers various products for detecting, diagnosing, and monitoring human disease. It also offers life science products that are processed from biological products. PT Diastika Biotekindo was founded in 1989 and is headquartered in Jakarta Timur, Jakarta Raya, Indonesia. PT… Read more
PT Diastika Biotekindo Tbk (CHEK) - Net Assets
Latest net assets as of : Rp- IDR
Based on the latest financial reports, PT Diastika Biotekindo Tbk (CHEK) has net assets worth Rp- IDR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp-) and total liabilities (Rp-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
PT Diastika Biotekindo Tbk - Net Assets Trend (None–None)
This chart illustrates how PT Diastika Biotekindo Tbk's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PT Diastika Biotekindo Tbk (None–None)
The table below shows the annual net assets of PT Diastika Biotekindo Tbk from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to PT Diastika Biotekindo Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
PT Diastika Biotekindo Tbk Competitors by Market Cap
The table below lists competitors of PT Diastika Biotekindo Tbk ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
iEntertainment Network Inc
PINK:IENT
|
$84.46 |
|
PANTERRA GOLD
BE:PTJ
|
$84.48 |
|
GCP Infrastructure Investments Limited
LSE:GCP
|
$85.00 |
|
AgriNurture Inc
PSE:ANI
|
$85.23 |
|
BLANTYRE HOTELS LIMITED
MSE:BHL
|
$84.05 |
|
Jpmorgan Global Core Real Assets Ltd
LSE:JARA
|
$83.96 |
|
PipeHawk plc
LSE:PIP
|
$83.95 |
|
Unicorn AIM VCT plc
LSE:UAV
|
$83.86 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PT Diastika Biotekindo Tbk's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares PT Diastika Biotekindo Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently PT Diastika Biotekindo Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares PT Diastika Biotekindo Tbk's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $23,760,605,959
- Average return on equity (ROE) among peers: 3.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PT Diastika Biotekindo Tbk (CHEK) | Rp- | N/A | N/A | $84.15 |
| PT UBC Medical Indonesia Tbk (LABS) | $9.23 Billion | 3.34% | 9.29x | $6.71 Million |
| Nanotech Indonesia Global Tbk PT (NANO) | $38.29 Billion | 3.24% | 0.09x | $3.72 Million |